CIBINQO
CIBINQO
Approved
DIN Number
02528363
Drug Class
Human
Market Date
Sep 29, 2022
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02528363
AIG Number0163862001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D11AH08 ABROCITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:24.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ABROCITINIBActive
Strength: 50 MG
Monograph: ABROCITINIB